Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $1.35 in the prior trading day, TNF Pharmaceuticals Inc (NASDAQ: TNFA) closed at $1.16, down -14.07%. In other words, the price has decreased by -$14.07 from its previous closing price. On the day, 0.11 million shares were traded. TNFA stock price reached its highest trading level at $1.3601 during the session, while it also had its lowest trading level at $1.135.
Ratios:
Our goal is to gain a better understanding of TNFA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.72 and its Current Ratio is at 1.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNFA now has a Market Capitalization of 3195881 and an Enterprise Value of -9777459.
Stock Price History:
Over the past 52 weeks, TNFA has reached a high of $10.66, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -20.81%, while the 200-Day Moving Average is calculated to be -44.10%.
Shares Statistics:
The stock has traded on average 34.12K shares per day over the past 3-months and 31610 shares per day over the last 10 days, according to various share statistics. A total of 2.76M shares are outstanding, with a floating share count of 2.60M. Insiders hold about 5.79% of the company’s shares, while institutions hold 1.60% stake in the company. Shares short for TNFA as of 1730332800 were 267349 with a Short Ratio of 8.55, compared to 1727654400 on 243632. Therefore, it implies a Short% of Shares Outstanding of 267349 and a Short% of Float of 10.850000399999999.
